Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 71335-2684

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 71335-2684). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac Sodium Dr Tablets Usp Structure)

Chemical Structure (Diclofenac Sodium Dr Tablets Usp Structure)
Chemical structure of diclofenac sodium depicted as two connected aromatic rings with chlorine atoms and a sodium carboxylate group, representing the active ingredient diclofenac sodium.*
FDA Label Image

Label (Lbl713352684)

Label (Lbl713352684)
Label for Diclofenac Sodium Delayed-Release Tablets USP, 75 mg strength, oral dosage form. The label indicates a package size of 28 tablets. It includes storage instructions, warnings, and dispensing requirements. The labeler is Bryant Ranch Prepack, and the manufacturer is Rubicon Research Limited. The NDC is 71335-2684-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.